{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T14:44:54Z","timestamp":1766760294876},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4S","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Plast Surg"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Treatment for melanoma after a positive sentinel lymph node biopsy includes nodal observation or lymphadenectomy. Important considerations for management, however, involve balancing the risk of recurrence and the risk of lymphedema after lymphadenectomy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>From the Merative MarketScan Research Databases, adult patients were queried from 2007 to 2021. <jats:italic toggle=\"yes\">International Classification of Disease<\/jats:italic>, <jats:italic toggle=\"yes\">Ninth<\/jats:italic> (<jats:italic toggle=\"yes\">ICD-9<\/jats:italic>) and <jats:italic toggle=\"yes\">Tenth<\/jats:italic> (<jats:italic toggle=\"yes\">ICD<\/jats:italic>-10) <jats:italic toggle=\"yes\">Editions<\/jats:italic>, diagnosis codes and <jats:italic toggle=\"yes\">Current Procedural Terminology<\/jats:italic> codes were used to identify patients with melanoma diagnoses who underwent an index melanoma excision with a positive sentinel lymph node biopsy (SLNB). Main outcomes were completion lymph node dissection (CLND) utilization after a positive SLNB, developing lymphedema with or without CLND, and nodal basin recurrence 3 months or more after index excision. Subanalyses stratified by index excision year (2007\u20132017 and 2018\u20132021) and propensity score matched were additionally conducted. Demographics and comorbidities (measured by Elixhauser index) were recorded.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 153,085,453 patients were identified. Of those, 359,298 had a diagnosis of melanoma, and 202,456 patients underwent an excision procedure. The study cohort comprised 3717 patients with a melanoma diagnosis who underwent an excision procedure and had a positive SLNB. The mean age of the study cohort was 49 years, 57% were male, 41% were geographically located in the South, and 24% had an Elixhauser index of 4+. Among the 350 patients who did not undergo CLND, 10% experienced recurrence and 22% developed lymphedema. A total of 3367 patients underwent CLND, of which 8% experienced recurrence and 20% developed lymphedema. Completion lymph node dissection did not significantly affect risk of recurrence [odds ratio (OR), 1.370, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.090] or lymphedema (OR, 1.114, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.438). After stratification and propensity score matching, odds of experiencing lymphedema (OR, 1.604, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.058) and recurrence (OR, 1.825, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.058) after CLND were not significantly affected. Rates of CLND had significantly decreased (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) overtime, without change in recurrence rate (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.063).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Electing for nodal observation does not increase the risk of recurrence or reduce risk of lymphedema. Just as CLND does not confer survival benefit, its decreased utilization has not increased recurrence rate.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sap.0000000000003867","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T04:09:03Z","timestamp":1711944543000},"page":"S284-S292","source":"Crossref","is-referenced-by-count":2,"title":["Lymphadenectomy After Melanoma\u2014A National Analysis of Recurrence Rates and Risk of Lymphedema"],"prefix":"10.1097","volume":"92","author":[{"given":"Chen","family":"Shen","sequence":"first","affiliation":[{"name":"Section of Plastic Reconstructive Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer K.","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Stanford University, Stanford, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila","family":"Cevallos","sequence":"additional","affiliation":[{"name":"Section of Plastic Reconstructive Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahim","family":"Nazerali","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Stanford University, Stanford, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph M.","family":"Rosen","sequence":"additional","affiliation":[{"name":"Section of Plastic Reconstructive Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20240401","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","year":"2006","journal-title":"N Engl J Med"},{"key":"bib2-20240401","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","year":"2014","journal-title":"N Engl J Med"},{"key":"bib3-20240401","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","year":"2017","journal-title":"N Engl J Med"},{"key":"bib4-20240401","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial","volume":"17","year":"2016","journal-title":"Lancet Oncol"},{"key":"bib5-20240401","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.18.02306","article-title":"Final analysis of DeCOG-SLT trial: no survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node","volume":"37","year":"2019","journal-title":"J Clin Oncol"},{"key":"bib6-20240401","article-title":"MarketScan Databases (Version 3.0) [Data set]","year":"2023","journal-title":"Redivis"},{"key":"bib7-20240401","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1245\/s10434-014-3758-7","article-title":"Observation after a positive sentinel lymph node biopsy in patients with melanoma","volume":"21","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"bib8-20240401","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1245\/ASO.2006.03.058","article-title":"Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study","volume":"13","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"bib9-20240401","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1245\/s10434-018-6812-z","article-title":"The role of completion lymph node dissection for sentinel lymph node-positive melanoma","volume":"26","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"bib10-20240401","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1245\/s10434-012-2652-4","article-title":"Evidence for a better nodal staging system for melanoma: the clinical relevance of metastatic disease confined to the sentinel lymph nodes","volume":"20","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"bib11-20240401","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10585-021-10099-7","article-title":"Current management of melanoma patients with nodal metastases","volume":"39","year":"2022","journal-title":"Clin Exp Metastasis"},{"key":"bib12-20240401","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1200\/JCO.2013.50.7681","article-title":"Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study","volume":"32","year":"2014","journal-title":"J Clin Oncol"},{"key":"bib13-20240401","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.amjsurg.2018.01.033","article-title":"Patients with sentinel lymph node positive melanoma: who needs completion lymph node dissection?","volume":"215","year":"2018","journal-title":"Am J Surg"},{"key":"bib14-20240401","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1245\/s10434-018-6647-7","article-title":"Prediction of residual nodal disease at completion dissection following positive sentinel lymph node biopsy for melanoma","volume":"25","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"bib15-20240401","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1245\/s10434-010-1203-0","article-title":"The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I)","volume":"17","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"bib16-20240401","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1200\/JCO.2007.15.4179","article-title":"Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"key":"bib17-20240401","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa2005493","article-title":"Five-year analysis of adjuvant dabrafenib plus trametinib in stage III melanoma","volume":"383","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000003867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T04:09:18Z","timestamp":1711944558000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000003867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":17,"journal-issue":{"issue":"4S","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000003867","relation":{},"ISSN":["1536-3708","0148-7043"],"issn-type":[{"value":"1536-3708","type":"electronic"},{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]}}}